Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Capital Employed: 2021-2025

Historic Return on Capital Employed for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to -0.24%.

  • Maravai Lifesciences Holdings' Return on Capital Employed fell 8.00% to -0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.24%, marking a year-over-year decrease of 8.00%. This contributed to the annual value of -0.20% for FY2024, which is 18.00% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Return on Capital Employed stood at -0.24%, which was up 35.54% from -0.37% recorded in Q2 2025.
  • Maravai Lifesciences Holdings' Return on Capital Employed's 5-year high stood at 0.33% during Q1 2022, with a 5-year trough of -0.37% in Q2 2025.
  • Moreover, its 3-year median value for Return on Capital Employed was -0.04% (2024), whereas its average is -0.09%.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Return on Capital Employed rose by 18bps in 2022 and then plummeted by 33bps in 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Return on Capital Employed (Quarterly) stood at 0.31% in 2021, then decreased by 4bps to 0.27% in 2022, then decreased by 28bps to -0.02% in 2023, then fell by 20bps to -0.22% in 2024, then fell by 8bps to -0.24% in 2025.
  • Its Return on Capital Employed was -0.24% in Q3 2025, compared to -0.37% in Q2 2025 and -0.29% in Q1 2025.